Urine protein excretion should be quantified by analysis of a 24-

Urine protein excretion should be quantified by analysis of a 24-hour urine collection or spot urine protein : creatinine ratio. Increased urine protein excretion usually excludes further consideration as a kidney donor. American Society of Transplantation Position Statement on the Medical Evaluation of Living Kidney Donors (2007): The following reasons will typically exclude a living donor

candidate from donating . . . ≥300 mg/day of proteinuria. 1 Conduct prospective, controlled studies on long-term living kidney donor outcomes. Include an assessment of the utility of urinary protein excretion compared with urinary albumin excretion; and outcomes of donors with isolated medical abnormalities. Both of the authors have no relevant financial affiliations that would cause a conflict of interest according to the conflict of interest statement Ulixertinib supplier set Apoptosis inhibitor down by CARI. “
“Aim:  Vancomycin and teicoplanin are the two most used glycopeptides for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin is suspected to have more nephrotoxicity but this has not been clearly established. The aim of this study was to assess its nephrotoxicity by a consensus definition of acute kidney injury (AKI): the risk (R), injury (I), failure (F), loss and end-stage renal disease

(RIFLE) classification. Methods:  Patients with MRSA bacteraemia who were prescribed either vancomycin or teicoplanin between 2003 and 2008 were classified. Patients who developed

AKI were classified by RIFLE criteria. click here Variables such as comorbidities, laboratory data and medical cost information were also obtained from the database. Outcomes determined were: (i) the rate of nephrotoxicity and mortality; and (ii) the association of nephrotoxicity with the length of hospital stay and costs. Results:  The study included 190 patients (vancomycin 33, teicoplanin 157). Fifteen patients on vancomycin and 27 patients on teicoplanin developed AKI (P = 0.0004). In the vancomycin group, four, eight and three patients were classified to RIFLE criteria R, I and F, respectively. In the teicoplanin group, 17, nine and one patient were classified to RIFLE criteria R, I and F, respectively. Kaplan–Meier analysis showed significant difference in time to nephrotoxicity for the vancomycin group compared to the teicoplanin group. No significant differences were found between the groups in terms of total mortality, length of hospital stay and costs. Conclusion:  The study data suggest that vancomycin is associated with a higher likelihood of nephrotoxicity using the RIFLE classification. “
“Aim:  Screening algorithms for chronic kidney disease have been developed and validated in American populations. Given the worldwide burden of kidney disease, developing algorithms for populations outside the USA is needed.

Comments are closed.